Inventor · disambiguated record
Jonathan Langille
Also filed as: LANGILLE JONATHAN
8 granted patents·5 pending applications·69 citations·filing 2004–2016
85Inventor score
Top patents by PatentIndex Score
13 records- 0193US8101647B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 24, 2012·35 cites·37 claims
- 0291US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 0389US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 0482US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 0573US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 0666US7491735B2Chemokine receptor binding compoundsGENZYME CORP·Filed 2004·Granted Feb 17, 2009·3 cites·6 claims
- 0756US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0853US2011269788A1Spiro-oxindole-derivatives as sodium channel blockersXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0952US7790747B2Chemokine receptor binding compoundsGENZYME CORP·Filed 2006·Granted Sep 7, 2010·0 cites·14 claims
- 1049US2009069408A1Tricyclic compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1147US2008234384A1Biaryl and biheteroaryl compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1244US7498346B2Chemokine receptor binding compoundsGENZYME CORP·Filed 2005·Granted Mar 3, 2009·0 cites·12 claims
- 1343US2010298366A1Chemokine receptor binding compoundsGENZYME CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Langille files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →